Search Results
Insights into a Phase II study evaluating ANX005 in wAIHA
Phase II study of ANX005 in patients with Huntington’s disease
ENERGY: Phase II/III study of nipocalimab in patients with wAIHA
The AIHA: How We're Advancing Research
The safety and efficacy of parsaclisib in autoimmune hemolytic anemia
The World of Rare Disease: wAIHA Warriors
Annexon Biosciences - Scott Borland
The Complement System
RESEARCH WEBINAR: ANNEXON BIOSCIENCES
Haemolytic anaemia live class part.5 #AutoImmuneAnamia #waiha #cad
How Janssen Immunology is Using Immune Pathway Science to Treat Rare Diseases
Improving CNS delivery and distribution of Huntington's disease therapies
